STXS
Stereotaxis, Inc. Common Stock
stockNYSEAMERICAN
stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. these innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. over 100 issued patents support the stereotaxis platform. the core components of stereotaxis' systems have received regulatory clearance in the united states, european union, japan, canada, china, and elsewhere. for more information, please visit www.stereotaxis.com.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.26 | 2026-09-28 | -5.95% | -0.571 |
| 1M | 1.39 | 2026-09-04 | -14.75% | 1.052 |
| 3M | 1.89 | 2026-07-06 | -37.30% | 1.138 |
| 6M | 1.88 | 2026-04-06 | -36.97% | 1.740 |
| 1Y | 3.14 | 2025-10-03 | -62.26% | 1.778 |
| 2Y | 2.04 | 2024-10-04 | -41.91% | — |
| 5Y | 5.28 | 2021-10-04 | -77.56% | 1.221 |
Stereotaxis, Inc. Common Stock (NYSEAMERICAN:STXS) stock price today is $1.19, and today's volume is 344,410. STXS is down 1.250% today. The 30 day average volume is 498,298. STXS market cap is $118.74M with 100.20M shares outstanding.